Gulf Coast TX
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial
Oct 20 (Reuters) -- Amgen and AstraZeneca said on Tuesday their asthma drug helped reduce swallowing difficulties and achieved disease remission in 69% of patients with a type of c…
